Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A children's cancer group study

Journal of Clinical Oncology

Volumn 18, Issue 3, 2000, Pages 477-486

  Nickerson, H James ^a   Matthay, Katherine K ^a   Seeger, Robert C ^a   Brodeur, Garret M ^a   Shimada, Hiroyuki ^a   Perez, Carlos ^a   Atkinson, James B ^a   Selch, Michael ^a   Gerbing, Robert B ^a   Stram, Daniel O ^a   Lukens, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033966153     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.3.477     Document Type: Article

References (51)

1. D'Angio G, Evans A, Koop C: Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1:1046-1049, 1971
2. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment [see comments]. J Clin Oncol 11:1466-1477, 1993
3. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 27:374-378, 1971
4. Evans AE, Chatten J, D'Angio GJ, et al: A review of 17 IV-S neuroblastoma patients at the Children's Hospital of Philadelphia. Cancer 45:833-839, 1980
5. Evans AE, Baum E, Chard R: Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 56:271-274, 1981
6. Grosfeld JL, Rescorla FJ, West KW, et al: Neuroblastoma in the first year of life: Clinical and biologic factors influencing outcome. Semin Pediatr Surg 2:37-46, 1993
7. Kushner BH, Cheung NK, LaQuaglia MP, et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996
8. Mancini AF, Rosito P, Vitelli A, et al: IV-S neuroblastoma: A cooperative study of 30 children. Med Pediatr Oncol 12:155-161, 1984
9. De Bernardi B, Pianca C, Boni L, et al: Disseminated neuroblastoma (stage IV and IV-S) in the first year of life: Outcome related to age and stage - Italian Cooperative Group on Neuroblastoma. Cancer 70:1625-1633, 1992
10. Martinez DA, King DR, Ginn-Pease ME, et al: Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: An analysis of 37 patients. J Pediatr Surg 27:1016-1020, discussion 1020-1021, 1992
11. Stephenson SR, Cook BA, Mease AD, et al: The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 58:372-375, 1986
12. Suarez A, Hartmann O, Vassal G, et al: Treatment of stage IV-S neuroblastoma: A study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol 19:473-477, 1991
13. Strother D, Shuster JJ, McWilliams N, et al: Results of Pediatric Oncology Group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol 17:254-259, 1995
14. Wilson PC, Coppes MJ, Solh H, et al: Neuroblastoma stage IV-S: A heterogeneous disease. Med Pediatr Oncol 19:467-472, 1991
15. McWilliams NB: IV-S neuroblastoma: Treatment controversy revisited. Med Pediatr Oncol 14:41-44, 1986
16. Nickerson HJ, Nesbit ME, Grosfeld JL, et al: Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 13:261-268, 1985
17. Brodeur GM, Seeger RC, Sather H, et al: Clinical implications of oncogene activation in human neuroblastomas. Cancer 58:541-545, 1986
18. Katzenstein HM, Bowman LC, Brodeur GM, et al: Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D S neuroblastoma: The Pediatric Oncology Group experience - A Pediatric Oncology Group study. J Clin Oncol 16:2007-2017, 1998
19. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
20. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
21. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
22. Hann HW, Evans AE, Siegel SE, et al: Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Childrens Cancer Study Group experience. Cancer Res 45:2843-2848, 1985
23. Schwab M, Varmus HE, Bishop JM: Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature 316:160-162, 1985
24. Crabbe DC, Peters J, Seeger RC: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1:229-234, 1992
25. Seeger RC, Wada R, Brodeur GM, et al: Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 271:41-49, 1988
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, Inc, 1980
28. Shaw A, Sabio H: Bilateral adrenal neuroblastoma. Am J Pediatr Hematol Oncol 6:41-43, 1984
29. Ishiguro Y, Iio K, Seo T, et al: Bilateral adrenal neuroblastoma. Eur J Pediatr Surg 4:37-39, 1994
30. Matthay KK, Perez C, Seeger RC, et al: Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 16:1256-1264, 1998
31. Berthold F, Harms D, Lampert F, et al: Risk factors in neuroblastoma of infants. Contrib Oncol 41:101-117, 1990
32. Guglielmi M, De Bernardi B, Rizzo A, et al: Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: Does it affect the clinical course? J Clin Oncol 14:1537-1544, 1996
33. Brodeur GM, Maris JM, Yamashiro DJ, et al: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19:93-101, 1997
34. Acharya S, Jayabose S, Kogan SJ, et al: Prenatally diagnosed neuroblastoma. Cancer 80:304-310, 1997
35. Haas D, Ablin AR, Miller C, et al: Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62:818-825, 1988
36. Hayashi Y, Inaba T, Hanada R, et al: Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants. Med Pediatr Oncol 17:111-115, 1989
37. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991
38. Tonini GP, Boni L, Pession A, et al: MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: The Italian experience with 295 children. J Clin Oncol 15:85-93, 1997
39. Bowman LC, Castleberry RP, Cantor A, et al: Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group study. J Natl Cancer Inst 89:373-380, 1997
40. Garvin J, Bendit I, Nisen PD: N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma. Cancer 65:2572-2575, 1990
41. Hachitanda Y, Hata J: Stage IVS neuroblastoma: A clinical, histological, and biological analysis of 45 cases. Hum Pathol 27:1135-1138, 1996
42. van Noesel MM, Heahlen K, Hakvoort-Cammel FG, et al: Neuroblastoma 4S: A heterogeneous disease with variable risk factors and treatment strategies. Cancer 80:834-843, 1997
43. Shimada H, Stram DO, Chatten J, et al: Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87:1470-1476, 1995
44. Siimes MA, Addiego JEJ, Dallman PR: Ferritin in serum: Diagnosis of iron deficiency and iron overload in infants and children. Blood 43:581-590, 1974
45. Segall ML, Heese HV, Dempster WS, et al: Serum ferritin: An evaluation of maternal and infant iron stores, in Stern L, Friis-Hansen B, Kildeberg P (eds): Intensive Care in the Newborn, I-IV. New York, NY, Masson, 1976-1983, pp 159-170
46. Silber JH, Evans AE, Fridman M: Models to predict outcome from childhood neuroblastoma: The role of serum ferritin and tumor histology. Cancer Res 51:1426-1433, 1991
47. Matthay KK: Stage 4S neuroblastoma: What makes it special? J Clin Oncol 16:2003-2006, 1998 (editorial)
48. Evans AE, Silber JH, Shpilsky A, et al: Successful management of low-stage neuroblastoma without adjuvant therapies: A comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 14:2504-2510, 1996
49. Blatt J, Deutsch M, Wollman MR: Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly. Int J Radiat Oncol Biol Phys 13:1467-1471, 1987
50. Halperin EC, Cox EB: Radiation therapy in the management of neuroblastoma: The Duke University Medical Center experience 1967-1984. Int J Radiat Oncol Biol Phys 12:1829-1837, 1986
51. Hsu LL, Evans AE, D'Angio GJ: Hepatomegaly in neuroblastoma stage 4s: Criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 27:521-528, 1996